AB Science reports the outcome from the interim analysis of study AB09004 in Alzheimer’s Disease

    NEXT STORY
    Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis
    PREV STORY
    OSE Immunotherapeutics Announces Results of 2019 Annual Shareholder Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2015 Financial Results on March 14, 2016

    PLYMOUTH MEETING, Pa., March 03, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced ...

    author_avatar
    NASDAQ Market News

    GeoVax Observes National Latinx AIDS Awareness Day

    ATLANTA, GA, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: ...

    author_avatar
    NASDAQ Market News

    CapsoVision, Inc. Announces CE Mark for the Use of CapsoCam Plus Capsule Endoscopy System in Patients Ages 2 and Above

    SARATOGA, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Today Silicon Valley-based CapsoVision, Inc. announced ...

    author_avatar
    NASDAQ Market News